PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1977; 70(Suppl 2): 7–15.
PMCID: PMC1543333

The pharmacological basis of the clinical use of dopamine.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Crumly HJ, Jr, Pinder RM, Hinshaw WB, Goldberg LI. Dopamine-like renal and mesenteric vasodilation caused by apomorphine 6-propylnorapomorphine and 2-amino-6, 7-dihydroxy-1,2,3,4-tetrahydronaphthalene. Nature. 1976 Feb 19;259(5544):584–587. [PubMed]
  • EBLE JN. A PROPOSED MECHANISM FOR THE DEPRESSOR EFFECT OF DOPAMINE IN THE ANESTHETIZED DOG. J Pharmacol Exp Ther. 1964 Jul;145:64–70. [PubMed]
  • Goldberg LI. Use of sympathomimetic amines in heart failure. Am J Cardiol. 1968 Aug;22(2):177–182. [PubMed]
  • Toda N, Goldberg LI. Effects of dopamine on isolated canine coronary arteries. Cardiovasc Res. 1975 May;9(3):384–389. [PubMed]
  • Goldberg LI, Yeh BK. Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines. Eur J Pharmacol. 1971 Jun;15(1):36–40. [PubMed]
  • GOLDBERG LI, MCDONALD RH, Jr, ZIMMERMAN AM. SODIUM DIURESIS PRODUCED BY DOPAMINE IN PATIENTS WITH CONGESTIVE HEART FAILURE. N Engl J Med. 1963 Nov 14;269:1060–1064. [PubMed]
  • Goldberg LI, Sonneville PF, McNay JL. An investigation of the structural requirements for dopamine-like renal vasodilation: phenylethylamines and apomorphine. J Pharmacol Exp Ther. 1968 Sep;163(1):188–197. [PubMed]
  • HORWITZ D, FOX SM 3D, GOLDBERG LI. Effects of Dopamine in man. Circ Res. 1962 Feb;10:237–243. [PubMed]
  • Iversen LL. Dopamine receptors in the brain. Science. 1975 Jun 13;188(4193):1084–1089. [PubMed]
  • MacCannell KL, McNay JL, Meyer MB, Goldberg LI. Dopamine in the treatment of hypotension and shock. N Engl J Med. 1966 Dec 22;275(25):1389–1398. [PubMed]
  • MCDONALD RH, Jr, GOLDBERG LI, MCNAY JL, TUTTLE EP., Jr EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW. J Clin Invest. 1964 Jun;43:1116–1124. [PMC free article] [PubMed]
  • McNay JL, Goldberg LI. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed]
  • Orme ML, Breckenridge A, Dollery CT. The effects of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol. 1973 Oct;6(3):150–155. [PubMed]
  • von Essen C. Effects of dopamine, noradrenaline and 5-hydroxytryptamine on the cerebral blood flow in the dog. J Pharm Pharmacol. 1972 Aug;24(8):668–668. [PubMed]
  • Yeh BK, McNay JL, Goldberg LI. Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor. J Pharmacol Exp Ther. 1969 Aug;168(2):303–309. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press